Cited 25 times in
Clinical implication of FDG-PET in advanced gastric cancer with signet ring cell histology.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 최승호 | - |
dc.contributor.author | 형우진 | - |
dc.contributor.author | 노성훈 | - |
dc.contributor.author | 박경호 | - |
dc.contributor.author | 윤미진 | - |
dc.contributor.author | 정재호 | - |
dc.date.accessioned | 2014-12-20T17:16:59Z | - |
dc.date.available | 2014-12-20T17:16:59Z | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 0022-4790 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/94304 | - |
dc.description.abstract | BACKGROUND AND OBJECTIVES: The purpose of this study was to investigate the role of the standardized uptake values (SUV), a semi-quantitative assessment of tumor FDG uptake, as a prognosticator for advanced signet ring cell carcinoma (SRC). METHODS: We reviewed the files of 41 patients who underwent curative gastrectomy for advanced SRC and who had an FDG-PET at initial presentation between September 2003 and December 2007. RESULTS: The median follow-up period was 30.9 months (range: 4.0-70.3). We found a correlation between the SUVmax and TNM stage. When the patients were divided into two groups (low vs. high SUVmax) based on a median SUVmax of 3.80, the high-SUVmax group showed more aggressive tumor behavior than did the low SUVmax group. In addition, the high SUVmax group showed more postoperative recurrence (P = 0.028), shorter relapse-free survival (P = 0.004), and lower 30-month cancer-specific survival rates (40.0% vs. 69.3%, P = 0.008). However, in multivariate analysis, SUVmax failed to be an independent predictor of overall survival. CONCLUSIONS: Although SUVmax of initial PET scan was not an independent predictor of patient outcomes after curative surgery, higher SUVmax is associated with more advanced stage and indicates more aggressive tumor biology in advanced SRC. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 566~570 | - |
dc.relation.isPartOf | JOURNAL OF SURGICAL ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Aged, 80 and over | - |
dc.subject.MESH | Carcinoma,SignetRingCell/diagnostic imaging* | - |
dc.subject.MESH | Carcinoma,SignetRingCell/pathology | - |
dc.subject.MESH | Carcinoma,SignetRingCell/surgery | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Fluorodeoxyglucose F18* | - |
dc.subject.MESH | Follow-Up Studies | - |
dc.subject.MESH | Gastrectomy | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Neoplasm Staging | - |
dc.subject.MESH | Positron-Emission Tomography* | - |
dc.subject.MESH | Radiopharmaceuticals* | - |
dc.subject.MESH | Stomach Neoplasms/diagnostic imaging* | - |
dc.subject.MESH | Stomach Neoplasms/pathology | - |
dc.subject.MESH | Stomach Neoplasms/surgery | - |
dc.subject.MESH | Survival Rate | - |
dc.subject.MESH | Treatment Outcome | - |
dc.title | Clinical implication of FDG-PET in advanced gastric cancer with signet ring cell histology. | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Surgery (외과학) | - |
dc.contributor.googleauthor | Kyung Ho Pak | - |
dc.contributor.googleauthor | Mijin Yun | - |
dc.contributor.googleauthor | Jae-Ho Cheong | - |
dc.contributor.googleauthor | Woo Jin Hyung | - |
dc.contributor.googleauthor | Seung Ho Choi | - |
dc.contributor.googleauthor | Sung Hoon Noh | - |
dc.identifier.doi | 10.1002/jso.21997 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A04102 | - |
dc.contributor.localId | A04382 | - |
dc.contributor.localId | A01281 | - |
dc.contributor.localId | A01426 | - |
dc.contributor.localId | A02550 | - |
dc.contributor.localId | A03717 | - |
dc.relation.journalcode | J01762 | - |
dc.identifier.eissn | 1096-9098 | - |
dc.identifier.pmid | 21671462 | - |
dc.identifier.url | http://onlinelibrary.wiley.com/doi/10.1002/jso.21997/abstract | - |
dc.subject.keyword | standard uptake values | - |
dc.subject.keyword | signet ring cell carcinoma | - |
dc.subject.keyword | FDG–PET | - |
dc.contributor.alternativeName | Choi, Seung Ho | - |
dc.contributor.alternativeName | Hyung, Woo Jin | - |
dc.contributor.alternativeName | Noh, Sung Hoon | - |
dc.contributor.alternativeName | Pak, Kyung Ho | - |
dc.contributor.alternativeName | Yun, Mi Jin | - |
dc.contributor.alternativeName | Cheong, Jae Ho | - |
dc.contributor.affiliatedAuthor | Choi, Seung Ho | - |
dc.contributor.affiliatedAuthor | Hyung, Woo Jin | - |
dc.contributor.affiliatedAuthor | Noh, Sung Hoon | - |
dc.contributor.affiliatedAuthor | Pak, Kyung Ho | - |
dc.contributor.affiliatedAuthor | Yun, Mi Jin | - |
dc.contributor.affiliatedAuthor | Cheong, Jae Ho | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 104 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 566 | - |
dc.citation.endPage | 570 | - |
dc.identifier.bibliographicCitation | JOURNAL OF SURGICAL ONCOLOGY, Vol.104(6) : 566-570, 2011 | - |
dc.identifier.rimsid | 27530 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.